Detalhe da pesquisa
1.
HDAC6 deficiency or inhibition blocks FGFR3 accumulation and improves bone growth in a model of achondroplasia.
Hum Mol Genet
; 25(19): 4227-4243, 2016 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27506979
2.
Mutant activated FGFR3 impairs endochondral bone growth by preventing SOX9 downregulation in differentiating chondrocytes.
Hum Mol Genet
; 24(6): 1764-73, 2015 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25432534
3.
The activities of MYC, MNT and the MAX-interactome in lymphocyte proliferation and oncogenesis.
Biochim Biophys Acta
; 1849(5): 554-62, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24731854
4.
A critical role for Mnt in Myc-driven T-cell proliferation and oncogenesis.
Proc Natl Acad Sci U S A
; 109(48): 19685-90, 2012 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-23150551
5.
HDAC6 deficiency or inhibition blocks FGFR3 accumulation and improves bone growth in a model of achondroplasia.
Hum Mol Genet
; 26(18): 3651, 2017 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28911208
6.
Disruption of a Sox9-ß-catenin circuit by mutant Fgfr3 in thanatophoric dysplasia type II.
Hum Mol Genet
; 21(21): 4628-44, 2012 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22843502
7.
Differential regulation of N-Myc and c-Myc synthesis, degradation, and transcriptional activity by the Ras/mitogen-activated protein kinase pathway.
J Biol Chem
; 286(44): 38498-38508, 2011 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-21908617
8.
OX40 engagement stabilizes Mxd4 and Mnt protein levels in antigen-stimulated T cells leading to an increase in cell survival.
Eur J Immunol
; 41(4): 1024-34, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21400495
9.
The role of senescence and prosurvival signaling in controlling the oncogenic activity of FGFR2 mutants associated with cancer and birth defects.
Hum Mol Genet
; 18(14): 2609-21, 2009 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19403560
10.
A novel role of MNT as a negative regulator of REL and the NF-κB pathway.
Oncogenesis
; 10(1): 5, 2021 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33419981
11.
Mnt-Max to Myc-Max complex switching regulates cell cycle entry.
J Cell Biol
; 169(3): 405-13, 2005 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-15866886
12.
Inflammatory disease and lymphomagenesis caused by deletion of the Myc antagonist Mnt in T cells.
Mol Cell Biol
; 26(6): 2080-92, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16507988
13.
Suppression of FGFR3- and MYC-dependent oncogenesis by tubacin: association with HDAC6-dependent and independent activities.
Oncotarget
; 9(3): 3172-3187, 2018 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29423038
14.
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas.
Cell Syst
; 6(3): 282-300.e2, 2018 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29596783
15.
Development of human gene reporter cell lines using rAAV mediated homologous recombination.
Biol Proced Online
; 9: 84-90, 2007 Dec 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-18464937
16.
MNT and Emerging Concepts of MNT-MYC Antagonism.
Genes (Basel)
; 8(2)2017 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28230739
17.
Mnt modulates Myc-driven lymphomagenesis.
Cell Death Differ
; 24(12): 2117-2126, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28800127
18.
Mnt transcriptional repressor is functionally regulated during cell cycle progression.
Oncogene
; 24(56): 8326-37, 2005 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16103876
19.
Correction: A novel role of MNT as a negative regulator of REL and the NF-κB pathway.
Oncogenesis
; 10(8): 57, 2021 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34341326
20.
Tbx3 impinges on the p53 pathway to suppress apoptosis, facilitate cell transformation and block myogenic differentiation.
Oncogene
; 21(24): 3827-35, 2002 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-12032820